title: Autophagy mechanism of right ventricular remodeling in murine model of pulmonary artery constriction.
abstract: Although right ventricular failure (RVF) is the hallmark of pulmonary arterial hypertension (PAH), the mechanism of RVF is unclear. Development of PAH-induced RVF is associated with an increased reactive oxygen species (ROS) production. Increases in oxidative stress lead to generation of nitro-tyrosine residues in tissue inhibitor of metalloproteinase (TIMPs) and liberate active matrix metalloproteinase (MMPs). To test the hypothesis that an imbalance in MMP-to-TIMP ratio leads to interstitial fibrosis and RVF and whether the treatment with folic acid (FA) alleviates ROS generation, maintains MMP/TIMP balance, and regresses interstitial fibrosis, we used a mouse model of pulmonary artery constriction (PAC). After surgery mice were given FA in their drinking water (0.03 g/l) for 4 wk. Production of ROS in the right ventricle (RV) was measured using oxidative fluorescent dye. The level of MMP-2, -9, and -13 and TIMP-4, autophagy marker (p62), mitophagy marker (LC3A/B), collagen interstitial fibrosis, and ROS in the RV wall was measured. RV function was measured by Millar catheter. Treatment with FA decreased the pressure to 35 mmHg from 50 mmHg in PAC mice. Similarly, RV volume in PAC mice was increased compared with the Sham group. A robust increase of ROS was observed in RV of PAC mice, which was decreased by treatment with FA. The protein level of MMP-2, -9, and -13 was increased in RV of PAC mice in comparison with that in the sham-operated mice, whereas supplementation with FA abolished this effect and mitigated MMPs levels. The protein level of TIMP-4 was decreased in RV of PAC mice compared with the Sham group. Treatment with FA helped PAC mice to improve the level of TIMP-4. To further support the claim of mitophagy occurrence during RVF, the levels of LC3A/B and p62 were measured by Western blot and immunohistochemistry. LC3A/B was increased in RV of PAC mice. Similarly, increased p62 protein level was observed in RV of PAC mice. Treatment with FA abolished this effect in PAC mice. These results suggest that FA treatment improves MMP/TIMP balance and ameliorates mitochondrial dysfunction that results in protection of RV failure during pulmonary hypertension.
authors.affiliation: Department of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, KY 40202, USA. n0qips01@louisville.edu
authors.forename: Natia
authors.initials: N
authors.lastname: Qipshidze
authors.forename: Neetu
authors.initials: N
authors.lastname: Tyagi
authors.forename: Naira
authors.initials: N
authors.lastname: Metreveli
authors.forename: David
authors.initials: D
authors.lastname: Lominadze
authors.forename: Suresh C
authors.initials: SC
authors.lastname: Tyagi
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000378:metabolism; D000818:Animals; D001343:Autophagy / Q000187:drug effects / Q000502:physiology*; D015415:Biomarkers / Q000378:metabolism; D004195:Disease Models, Animal; D005492:Folic Acid / Q000494:pharmacology; D006352:Heart Ventricles / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D017380:Hypertrophy, Right Ventricular / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D053509:Matrix Metalloproteinase 13 / Q000378:metabolism; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D011651:Pulmonary Artery / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D017382:Reactive Oxygen Species / Q000378:metabolism; D019714:Tissue Inhibitor of Metalloproteinases / Q000378:metabolism; D020257:Ventricular Remodeling / Q000187:drug effects / Q000502:physiology*; D014803:Vitamin B Complex / Q000494:pharmacology; D000097792:Tissue Inhibitor of Metalloproteinase-4
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D015415:Biomarkers; D005492:Folic Acid; D053509:Matrix Metalloproteinase 13; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D017382:Reactive Oxygen Species; D019714:Tissue Inhibitor of Metalloproteinases; D014803:Vitamin B Complex; D000097792:Tissue Inhibitor of Metalloproteinase-4; C507081:Mmp13 protein, mouse; C522362:Mmp2 protein, mouse; C501830:Mmp9 protein, mouse
references.citation: Antioxid Redox Signal. 2003 Dec;5(6):789-94
references.pmid: 14588152
references.citation: J Cell Biochem. 2005 Nov 1;96(4):665-71
references.pmid: 16149054
references.citation: Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H890-7
references.pmid: 18567713
references.citation: Cell. 2007 Dec 14;131(6):1149-63
references.pmid: 18083104
references.citation: Int J Biochem Cell Biol. 2005 Dec;37(12):2478-503
references.pmid: 16103002
references.citation: Am J Physiol. 1989 Aug;257(2 Pt 1):C347-54
references.pmid: 2764095
references.citation: Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2649-56
references.pmid: 16085680
references.citation: Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H461-8
references.pmid: 15650153
references.citation: Arch Dermatol Res. 1998 Jul;290 Suppl:S30-6
references.pmid: 9710381
references.citation: Cardiovasc Res. 2007 Sep 1;75(4):770-81
references.pmid: 17582388
references.citation: Atherosclerosis. 1995 Jul;116(1):43-57
references.pmid: 7488332
references.citation: Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1712-20
references.pmid: 15142841
references.citation: Clin Exp Hypertens. 2002 Jul;24(5):397-406
references.pmid: 12109779
references.citation: Br J Nutr. 1974 Sep;32(2):457-69
references.pmid: 4417592
references.citation: Cardiovasc Res. 2003 Sep 1;59(3):658-67
references.pmid: 14499867
references.citation: Pharmacology. 2008;82(3):201-13
references.pmid: 18810244
references.citation: Mol Cell Biochem. 1993 Sep 8;126(1):49-59
references.pmid: 8107689
references.citation: Mol Cell Biochem. 2004 May;260(1-2):21-9
references.pmid: 15228082
references.citation: Arch Physiol Biochem. 2006 Oct-Dec;112(4-5):219-27
references.pmid: 17178594
references.citation: Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1229-35
references.pmid: 12775562
references.citation: Nature. 2007 Jun 14;447(7146):859-63
references.pmid: 17568747
references.citation: Heart Dis. 2003 Sep-Oct;5(5):308-12
references.pmid: 14503927
references.citation: J Cell Biochem. 2001;80(4):512-21
references.pmid: 11169735
references.citation: J Cell Sci. 2008 Aug 15;121(Pt 16):2685-95
references.pmid: 18653543
references.citation: Reprod Toxicol. 2007 Jun;23(4):486-98
references.pmid: 17482424
references.citation: Biochim Biophys Acta. 2000 Mar 7;1477(1-2):267-83
references.pmid: 10708863
references.citation: Chest. 2005 Jun;127(6):1898-903
references.pmid: 15947300
references.citation: Circulation. 2004 Oct 5;110(14):2010-6
references.pmid: 15451801
references.citation: Am J Physiol. 1993 Apr;264(4 Pt 1):C961-7
references.pmid: 8386454
references.citation: Trends Pharmacol Sci. 2005 Jun;26(6):302-10
references.pmid: 15925705
references.citation: Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H1858-64
references.pmid: 15937097
references.citation: J Am Coll Cardiol. 2006 Aug 15;48(4):824-32
references.pmid: 16904556
references.citation: EMBO J. 2000 Apr 3;19(7):1576-86
references.pmid: 10747026
references.citation: Free Radic Biol Med. 2005 Jul 1;39(1):71-80
references.pmid: 15925279
references.citation: Neurochem Int. 2008 Dec;53(6-8):214-9
references.pmid: 18725259
references.citation: Clin Exp Nephrol. 2003 Mar;7(1):63-6
references.pmid: 14586746
references.citation: Hypertension. 2002 Oct;40(4):477-84
references.pmid: 12364350
references.citation: J Biol Chem. 2007 Aug 17;282(33):24131-45
references.pmid: 17580304
references.citation: Eur Respir J. 2010 Jun;35(6):1286-93
references.pmid: 19897557
references.citation: J Cell Physiol. 2011 Oct;226(10):2712-20
references.pmid: 21792928
references.citation: J Cell Biol. 2005 Nov 21;171(4):603-14
references.pmid: 16286508
references.citation: J Clin Invest. 1998 Mar 15;101(6):1478-87
references.pmid: 9502791
references.citation: Am J Physiol Cell Physiol. 2009 Apr;296(4):C840-7
references.pmid: 19193866
references.citation: Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1484-93
references.pmid: 20802128
references.citation: Circ Res. 2010 Mar 5;106(4):796-808
references.pmid: 20056917
references.citation: J Cell Biochem. 2006 Aug 1;98(5):1150-62
references.pmid: 16514665
references.citation: Arch Physiol Biochem. 2010 May;116(2):63-72
references.pmid: 20230216
references.citation: Circulation. 2008 May 20;117(20):2626-36
references.pmid: 18474817
references.citation: J Am Coll Cardiol. 2002 Mar 6;39(5):907-12
references.pmid: 11869860
references.citation: Basic Res Cardiol. 2003 Sep;98(5):285-94
references.pmid: 12955401
references.citation: J Clin Invest. 1996 Jul 1;98(1):5-7
references.pmid: 8690803
references.citation: J Mol Med (Berl). 2010 Oct;88(10):1011-20
references.pmid: 20820751
references.citation: Transplantation. 2007 Dec 15;84(11):1474-82
references.pmid: 18091524
references.citation: Nat Protoc. 2008;3(9):1422-34
references.pmid: 18772869
references.citation: J Am Coll Cardiol. 1996 Aug;28(2):506-14
references.pmid: 8800132
references.citation: EMBO J. 2000 Nov 1;19(21):5720-8
references.pmid: 11060023
references.citation: Circulation. 2008 Apr 8;117(14):1810-9
references.pmid: 18362233